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Figure 1. A horse in the classic neurologic 
“dog sitting” stance that is unable to rise into 
a normal stance. (Photo courtesy of Dr. 
George Allen) 
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Background 
Equine Herpes Virus (EHV) can affect the respiratory, 
reproductive, and nervous systems causing a wide 
variety of diseases. Of the nine types of herpes virus 
found in equidae, type-1 (EHV-1), type-3 (EHV-3), and 
type-4 (EHV-4) are commonly found in horses. EHV-1, 
EHV-3, and EHV-4 are genetically and antigenically 
distinct groups of herpes viruses. These viruses are 
ubiquitous in horse populations worldwide. EHV-1 and 
EHV-4 cause an acute febrile respiratory disease called 
Rhinopneumonitis. EHV-3 causes coital exanthema, a 
contagious genital infection (vulva in mares, penis and 
scrotum in stallions). Horse owners routinely vaccinate 
at least twice per year for Rhinopneumonitis. EHV is 
spread by direct contact from horse to horse. 
The herpes virus has a unique adaptive mechanism to 
ensure survival. The virus, once infected, can become 
latent. Latency enables the virus to avoid the host’s 
immune system. Then at an opportune time (i.e., levels 
of high stress) the virus emerges and can be silently 
shed, infecting other horses that come into contact with 
the “silent” shedder. 
In rare cases, EHV-1 can also cause neurologic disease. 
While this phenomenon has been recognized for quite 
some time, there seems to be an alarming increase in 
frequency of this disease. Researchers have identified a 
genetic mutation within a single EHV-1 gene that is 
associated with strains that cause neurologic disease. 
While it is still unclear how this mutation causes the 
virus to have increased affinity for nervous tissue, 
further research is ongoing to determine this affect. 
Clinical Signs 
Neurologic EHV-1 can cause an acute paralytic 
syndrome in horses where they are weak and ataxic in 
the hind legs. This weakness and paralysis of the 
muscles of the hind limbs gives rise to incoordination, 
gait abnormalities and, in some cases, the inability to 
rise from the sitting position. This “dog sitting” stance 
can be associated with EHV-1 (Figure 1). The 
neurologic disease can progress to full recumbency. 
Horses are often humanely euthanized once full 
recumbency is reached. There have been reports of urine 
scalding or dribbling with cases of EHV-1 as urinary 
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Treatment of neurologic EHV-1 revolves around 
supportive care to prevent further injury while the horses 
are recumbent or exhibiting neurologic signs. There are 
no antiviral treatments approved for EHV-1.  This 
supportive care may include fluids and anti-
inflammatory drugs to minimize the side effects from the 
disease. The biggest challenge with caring for this 
neurologic disease is to provide support when the horse 
becomes recumbent. Horses in this condition can cause 
significant self-inflicted trauma as they struggle to stand. 
Vaccination 
There is not a vaccine available that affords protection to 
the neurologic form of EHV-1. Opinions vary on the 
question, should I use the current vaccines for 
Rhinopneumonitis (EHV-1 and EHV-4) to provide cross 
protection and therefore helping to prevent the 
neurologic form of EHV-1? While this debate continues, 
vaccinating for other EHV diseases is a sound preventive 
health decision (i.e., Rhinopneumonitis and abortion). 
Therefore, it is recommended that horses continue to be 
vaccinated for EHV-1 and EHV-4, depending on their 
specific disease risk, to prevent the respiratory and 
reproductive forms of the disease.  
Not all equine neurologic disease is caused by EHV-1. 
Other diseases that can cause neurologic signs are: 
• Equine encephalitis (EEE, WEE) 
• Tetanus 
• West Nile Virus (WNV) 
• Cervical Stenosis (Wobblers Disease) 
• Equine Protozoal Myeloencephalitis (EPM) 
 It is important that you consult a veterinarian should 
your horse exhibit any signs of neurologic disease. 
Prevention 
Preventive measures are focused on good sound 
biosecurity principles to prevent the exposure and spread 
of EHV. Sound preventative principles include: 
1. Not sharing tack 
2. Cleaning and disinfecting your horse trailer after 
transporting horses other than your own 
3. Proper food, water, and shelter to minimize 
stress 
4. Isolate new additions to your herd for a 
minimum of 30 days 
5. Contacting your veterinarian immediately 
should your horse exhibit any neurologic signs 
6. Making sure your horse is annually vaccinated 
for other causes of neurologic disease (e.g., 
EEE/WEE, Tetanus, WNV, and EPM (if 
endemic in your area)) 
While these simple measures will not guarantee 
prevention of EHV-1 they will go a long way in 
minimizing exposure and risk. 
Summary 
Although previously recognized as causing neurologic 
disease in horses, Equine Herpes Virus Type-1 (EHV-1) 
has been emerging as a more common neurologic 
phenomenon. It is not fully understood why this 
emergence is happening and ongoing research is trying 
to work out the puzzle. Current vaccinations do not 
provide protection against neurologic EHV-1. Horse 
owners should consult their veterinarian to determine 
which vaccinations should be given in their area to 
minimize the risk for other EHV diseases. Without a 
proven vaccine, horse owners should be extremely 
vigilant in observing basic biosecurity principles to 
minimize the risk of disease transmission to their horses. 
And finally, consult your veterinarian immediately 
should your horse exhibit any neurologic signs. 
Additional Information 
The United States Department of Agriculture (USDA), 
Animal and Plant Health Inspection Service (APHIS), 
Veterinary Services (VS) has generated a fact sheet on 
the emerging phenomena of neurologic EHV-1. This 
USDA, APHIS, VS fact sheet can be accessed online at: 
http://www.aphis.usda.gov/vs/ceah/cei/taf/emergingdise
asenotice_files/ehv.pdf 
Several institutions are doing research on EHV-1. The 
Gluck Equine Research Center at the University of 
Kentucky has developed a Web site with extensive 
information and literature search regarding EHV-1. It is 
accessed through the following link: 
http://www.ca.uky.edu/gluck/BiblioEHV1.asp 
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